Financials KORU Medical Systems, Inc.
Equities
KRMD
US7599101026
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.155 USD | -3.36% | -8.47% | -12.02% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 257.9 | 264.5 | 133.7 | 161.6 | 112.1 | 102.1 | - | - |
Enterprise Value (EV) 1 | 257.9 | 264.5 | 133.7 | 161.6 | 112.1 | 102.1 | 102.1 | 102.1 |
P/E ratio | 653 x | -201 x | -30 x | -18.8 x | -8.18 x | -14.1 x | -26.5 x | -66.9 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 11.1 x | 10.9 x | 5.69 x | 5.79 x | 3.93 x | 3.21 x | 2.71 x | 2.28 x |
EV / Revenue | 11.1 x | 10.9 x | 5.69 x | 5.79 x | 3.93 x | 3.21 x | 2.71 x | 2.28 x |
EV / EBITDA | 45.9 x | 72.3 x | -75.3 x | -26.5 x | -18.6 x | -27.9 x | 255 x | 24.9 x |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 39,502 | 43,943 | 44,561 | 45,280 | 45,669 | 45,764 | - | - |
Reference price 2 | 6.530 | 6.020 | 3.000 | 3.570 | 2.455 | 2.230 | 2.230 | 2.230 |
Announcement Date | 2/25/20 | 3/23/21 | 3/2/22 | 3/8/23 | 3/13/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 23.16 | 24.18 | 23.49 | 27.9 | 28.52 | 31.75 | 37.64 | 44.83 |
EBITDA 1 | 5.615 | 3.661 | -1.775 | -6.096 | -6.03 | -3.66 | 0.4 | 4.101 |
EBIT 1 | 0.5857 | 1.606 | -5.598 | -10.78 | -10.27 | -7.949 | -4.627 | -1.902 |
Operating Margin | 2.53% | 6.64% | -23.83% | -38.65% | -36.01% | -25.04% | -12.29% | -4.24% |
Earnings before Tax (EBT) 1 | 0.6964 | -1.194 | -6.364 | -10.68 | -9.774 | -7.829 | -4.491 | -1.729 |
Net income 1 | 0.5644 | -1.212 | -4.563 | -8.661 | -13.74 | -7.317 | -4.023 | -1.546 |
Net margin | 2.44% | -5.01% | -19.42% | -31.05% | -48.18% | -23.05% | -10.69% | -3.45% |
EPS 2 | 0.0100 | -0.0300 | -0.1000 | -0.1900 | -0.3000 | -0.1580 | -0.0840 | -0.0333 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/25/20 | 3/23/21 | 3/2/22 | 3/8/23 | 3/13/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 6.491 | 6.244 | 6.547 | 7.76 | 7.345 | 7.393 | 6.936 | 7.003 | 7.186 | 8.198 | 7.577 | 7.845 | 8.088 | 9.111 | 9.097 |
EBITDA 1 | -0.5853 | -1.854 | -2.367 | -0.3751 | -1.552 | -1.97 | -2.207 | -0.8903 | -0.9627 | -0.9427 | -1.153 | -0.7993 | -0.6457 | 0.037 | -0.113 |
EBIT 1 | -2.111 | -2.794 | -3.293 | -1.529 | -2.511 | -3.008 | -3.218 | -1.791 | -2.198 | -1.961 | -2.25 | -1.964 | -1.77 | -1.237 | -1.37 |
Operating Margin | -32.53% | -44.74% | -50.3% | -19.71% | -34.19% | -40.69% | -46.4% | -25.57% | -30.58% | -23.93% | -29.7% | -25.03% | -21.89% | -13.58% | -15.06% |
Earnings before Tax (EBT) 1 | -1.444 | -3.135 | -3.632 | -1.497 | -2.411 | -2.988 | -3.096 | -1.669 | -2.021 | -1.936 | -2.21 | -1.944 | -1.73 | -1.197 | -1.33 |
Net income 1 | -1.068 | -2.538 | -2.921 | -1.226 | -1.977 | -2.411 | -2.496 | -1.368 | -7.466 | -1.936 | -2.018 | -1.789 | -1.566 | -1.107 | -1.211 |
Net margin | -16.46% | -40.64% | -44.62% | -15.79% | -26.91% | -32.61% | -35.98% | -19.54% | -103.9% | -23.62% | -26.63% | -22.8% | -19.36% | -12.15% | -13.31% |
EPS 2 | -0.0200 | -0.0600 | -0.0700 | -0.0300 | -0.0400 | -0.0500 | -0.0500 | -0.0300 | -0.1600 | -0.0400 | -0.0420 | -0.0400 | -0.0360 | -0.0233 | -0.0267 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/2/22 | 5/4/22 | 8/3/22 | 11/9/22 | 3/8/23 | 5/4/23 | 8/9/23 | 11/8/23 | 3/13/24 | 5/1/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | - | - | 0.78 | 0.5 | 0.6 | - |
Capex / Sales | - | - | - | - | 2.75% | 1.57% | 1.59% | - |
Announcement Date | 2/25/20 | 3/23/21 | 3/2/22 | 3/8/23 | 3/13/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.76% | 102M | |
-5.27% | 182B | |
+1.23% | 114B | |
-4.86% | 67.76B | |
+3.48% | 51.91B | |
+7.16% | 43.23B | |
+6.07% | 41.07B | |
+22.99% | 32.07B | |
+15.86% | 25B | |
-2.37% | 24.55B |
- Stock Market
- Equities
- KRMD Stock
- Financials KORU Medical Systems, Inc.